Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β‐thalassaemic patients*
Adult
Male
Erythrocytes
Hemoglobin E
Antithrombin III
beta-Thalassemia
Phosphatidylserines
Peptide Fragments
3. Good health
03 medical and health sciences
0302 clinical medicine
Chronic Disease
Splenectomy
Humans
Thrombophilia
Female
Prothrombin
Peptide Hydrolases
DOI:
10.1046/j.1365-2141.2002.03711.x
Publication Date:
2003-03-11T06:47:01Z
AUTHORS (7)
ABSTRACT
Summary. Small pulmonary arterial thromboses can occur following splenectomy of patients with haemoglobin E/β‐thalassaemia (Hb E/β‐thal). We compared plasma markers of coagulation activation in vivo and red blood cell (RBC) markers of procoagulant activity in 15 Hb E/β‐thal patients who were not splenectomized (NS), 15 who had been splenectomized (S), and 15 normal controls (NC). Levels of plasma thrombin–antithrombin III complex (TAT) were significantly higher in the S group than in either the NS or the NC groups, and levels of prothrombin fragment 1.2 (F 1.2) were significantly higher in the S than in the NC group. Diluted Russell's viper venom clotting times were significantly shorter when RBCs from group S patients were added to the assay compared with RBCs from the NC group. Phosphatidylserine (PS) expression (% of annexin V‐positive RBCs) on the outer leaflet of RBC membrane of both ‘larger’‐ and ‘smaller’‐sized RBCs was significantly higher for the S than the NC group. The RBC PS expression of the S and the NS groups, respectively, accounted for 25·3% (P = 0·174) and 6·3% (P = 0·675) of the variation in plasma TAT levels. Our findings indicated that, when compared with NC, splenectomized patients with Hb E/β‐thal were in a chronic low‐grade hypercoagulable state associated with increased numbers of circulating PS exposed RBCs. This condition may have a role in the risk of these patients for pulmonary arterial thromboses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (100)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....